Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient? - Wikidata - awgldk - TriplyDB

Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?

Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?

http://www.wikidata.org/entity/Q37010967

about

Patients' conceptions of their own influence on good treatment response to biological therapy in chronic inflammatory arthritis.

P2860

Q33865344-1BCBE07F-18BB-4F8A-BE36-16BA398EBC1C

P2860

Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?

http://www.wikidata.org/entity/Q37010967

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Optimal responses in disease a ...... reduction of >1.2 sufficient?

@en

Optimal responses in disease a ...... reduction of >1.2 sufficient?

@nl

type

label

Optimal responses in disease a ...... reduction of >1.2 sufficient?

@en

Optimal responses in disease a ...... reduction of >1.2 sufficient?

@nl

prefLabel

Optimal responses in disease a ...... reduction of >1.2 sufficient?

@en

Optimal responses in disease a ...... reduction of >1.2 sufficient?

@nl

P1433

Q37010967-01BCA330-5CD3-4FF1-965B-EE8585196C96

P1476

Q37010967-43AAEB3F-8073-4724-8165-F9C7DCFDBD12

P2093

Q37010967-117A7DEC-364A-4316-B385-006CC2D1E6FA

Q37010967-4EE273EB-75B9-4FE7-96E5-A37058C5BCC0

Q37010967-FB22E320-4099-4F2C-98AE-C614F3DA100C

Q37010967-FC72A3D7-418C-4977-935F-237E80CA7E67

P2860

Q37010967-029D4D0A-DF1B-4C60-B50B-577986CB4C87

Q37010967-075BE8C1-5575-4757-9D42-53D5BA2F00DF

Q37010967-0FAB12FA-6CF1-4E49-8FFE-9CF0E10504D3

Q37010967-1D6E0B76-FDD5-4AEB-B25A-7E5E006FEADD

Q37010967-362E43EA-DE86-4AA5-8DD0-D89BD17C3C49

Q37010967-59881732-6767-4C94-A1D2-E944CB9CF4F7

Q37010967-61B56509-F3CF-4C54-8964-FED0F660E197

Q37010967-6CEF6E8D-CF25-4AF6-80EA-1E90F5D40EB8

Q37010967-A121E61C-C396-4CFD-B4F9-7C61D96120ED

Q37010967-AEA62EEF-62DC-43E2-AD11-BA98EAB5FF57

P2888

Q37010967-E81E23A7-97E0-421B-B324-C95EBD9A1858

P304

Q37010967-2F075803-437D-440A-B94F-BCD5E3F47295

P31

Q37010967-4495E24D-59BA-4FFD-B5E1-A41EE295C387

P356

Q37010967-3D029A95-4F9C-418D-8AD5-A64AD9EB7E1A

P433

Q37010967-DD5402D6-D428-41F3-8A62-DEF30A6E8F70

P478

Q37010967-B0D25573-CDA3-43BF-B514-0D13035844CC

P50

Q37010967-E56ACC84-BC46-4FCB-A500-8CCDF07E2143

P577

Q37010967-2181BB65-AF0F-477C-AC27-FDB27753DC28

P698

Q37010967-55563891-09B3-41EA-84FD-19D3ACAC8C93

P932

Q37010967-74BE79E7-0693-49AB-81B1-3E0304A2DB54

P356

S13075-016-1028-8

P1433

Arthritis Research and Therapy

P1476

Optimal responses in disease a ...... reduction of >1.2 sufficient?

@en

P2093

Aneela N Mian

http://www.w3.org/2001/XMLSchema#string

David L Scott

http://www.w3.org/2001/XMLSchema#string

Fowzia Ibrahim

http://www.w3.org/2001/XMLSchema#string

TITRATE study group

http://www.w3.org/2001/XMLSchema#string

P2860

The Stanford Health Assessment Questionnaire: dimensions and practical applications

Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.

Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.

Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents

Brief report: rheumatoid arthritis response criteria and patient-reported improvement in arthritis activity: is an American College of Rheumatology twenty percent response meaningful to patients?

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

The Disease Activity Score and the EULAR response criteria.

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.

P2888

s13075-016-1028-8

P304

142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-016-1028-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

James B Galloway

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27312203

http://www.w3.org/2001/XMLSchema#string

P932

4910246

http://www.w3.org/2001/XMLSchema#string